+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Immunocore Hldgs

IMCRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$30.83

-1.08-3.38%

At close: -

$30.83

00.00%

After Hours: 4:00 PM EDT

15 minutes delayed

Immunocore Hldgs (IMCR) Forecast

News

Earnings Immunocore Hldgs (IMCR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Immunocore Hldgs (NASDAQ:IMCR) Stock

Immunocore Hldgs Stock (NASDAQ: IMCR)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, October 24, 2024

A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
Benzinga Insights
UBS Initiates Coverage On Immunocore Hldgs wi...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk

Friday, October 11, 2024

Morgan Stanley Maintains Overweight on Immuno...
Benzinga Newsdesk

Monday, October 07, 2024

Analyst Ratings For Immunocore Hldgs
Benzinga Insights
Guggenheim Downgrades Immunocore Hldgs to Neu...
Benzinga Newsdesk

Tuesday, September 17, 2024

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Analyst Expectations For Immunocore Hldgs's Future
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk
Needham Maintains Buy on Immunocore Hldgs, Lo...
Benzinga Newsdesk

Monday, September 16, 2024

Reported Saturday, Immunocore Presented Phase...
Benzinga Newsdesk

Monday, September 09, 2024

Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk

Thursday, August 29, 2024

Immunocore CFO And Head Of Strategy, Brian Di...
Benzinga Newsdesk

Wednesday, August 28, 2024

The Latest Analyst Ratings For Immunocore Hldgs
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk

Friday, August 09, 2024

Oppenheimer Reiterates Outperform on Immunoco...
Benzinga Newsdesk
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
Benzinga Insights
Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk

Thursday, August 08, 2024

Immunocore Hldgs Q2 2024 GAAP EPS $(0.23) Bea...
Benzinga Newsdesk

Wednesday, July 10, 2024

Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
Benzinga Insights
JP Morgan Maintains Overweight on Immunocore ...
Benzinga Newsdesk

Tuesday, June 18, 2024

Immunocore Announces Randomization Of The Fir...
Benzinga Newsdesk

Wednesday, June 05, 2024

HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk

Monday, June 03, 2024

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk

Friday, May 31, 2024

Immunocore Reports Updated Phase 1 Brenetafus...
Benzinga Newsdesk

Thursday, May 30, 2024

HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk

Wednesday, May 29, 2024

Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk
Following Consultation With FDA, Immunocore C...
Benzinga Newsdesk

Friday, May 24, 2024

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk
Analyst Expectations For Immunocore Hldgs's Future
Benzinga Insights
Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk

Monday, May 13, 2024

Mizuho Maintains Buy on Immunocore Hldgs, Low...
Benzinga Newsdesk

Thursday, May 09, 2024

Canaccord Genuity Maintains Hold on Immunocor...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Immunoco...
Benzinga Newsdesk
Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk

Monday, April 29, 2024

Where Immunocore Hldgs Stands With Analysts
Benzinga Insights
Leerink Partners Initiates Coverage On Immuno...
Benzinga Newsdesk

Tuesday, April 23, 2024

Guggenheim Reiterates Buy on Immunocore Hldgs...
Benzinga Newsdesk

Thursday, April 11, 2024

Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Benzinga Insights
Needham Reiterates Buy on Immunocore Hldgs, M...
Benzinga Newsdesk

Friday, April 05, 2024

Immunocore Says Selling Shareholders May Offe...
Benzinga Newsdesk

Thursday, March 21, 2024

JP Morgan Maintains Overweight on Immunocore ...
Benzinga Newsdesk
Immunocore Filed For Mixed Shelf Up To $250M ...
Charles Gross

Wednesday, March 06, 2024

HC Wainwright & Co. Reiterates Buy on Immunoc...
Benzinga Newsdesk

Tuesday, March 05, 2024

Mizuho Maintains Buy on Immunocore Hldgs, Rai...
Benzinga Newsdesk

Thursday, February 29, 2024

Key Takeaways From Immunocore Hldgs Analyst Ratings
Benzinga Insights
Oppenheimer Reiterates Outperform on Immunoco...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Immunocor...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved